mortality/aging
|
• mice die within 19 weeks (range 7-19 weeks, average 11.5 weeks) after AdCre injection into the ovarian bursa and development of ovarian tumors
|
neoplasm
|
• 8-10 week old mice injected with an adenovirus expressing cre recombinase (AdCre) into the right ovarian bursa develop ovarian carcinoma with 100% penetrance within 6 weeks of AdCre injection
• tumors show similarity to human ovarian endometrioid adenocarcinoma, with formation of distinct glands and occasional foci of squamous differentiation
|
endocrine/exocrine glands
|
• 8-10 week old mice injected with an adenovirus expressing cre recombinase (AdCre) into the right ovarian bursa develop ovarian carcinoma with 100% penetrance within 6 weeks of AdCre injection
• tumors show similarity to human ovarian endometrioid adenocarcinoma, with formation of distinct glands and occasional foci of squamous differentiation
|
homeostasis/metabolism
|
• 76% of ovarian bursa AdCre injected mice develop hemorrhagic ascites and 21% develop overt peritoneal dissemination of tumors
|
reproductive system
|
• 8-10 week old mice injected with an adenovirus expressing cre recombinase (AdCre) into the right ovarian bursa develop ovarian carcinoma with 100% penetrance within 6 weeks of AdCre injection
• tumors show similarity to human ovarian endometrioid adenocarcinoma, with formation of distinct glands and occasional foci of squamous differentiation
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
ovarian cancer | DOID:2394 |
OMIM:167000 OMIM:607893 |
J:120955 |